Stock report · Delisted · Nasdaq
Entero Therapeutics, Inc. (ENTO)
2.85USD Delisted Final close · Jan 29, 2026
ENTO no longer trades. Entero Therapeutics was delisted from the Nasdaq in January 2026.
All prices on this page are historical. The last trade was on January 29, 2026, at $2.85.
ENTO stock price history
Final trading statistics
- Final close
- $2.85
- Final trading day
- Jan 29, 2026
- Market cap at delisting
- $9.58M
- Shares outstanding
- 3.36M
- Final 52-week range
- $0.32 – $5.84
- Avg. volume (final 3 mo.)
- 124,986
- All-time high
- $690480.00 · Oct 2016
- All-time low
- $0.71 · Aug 2024
- Return since IPO
- -100.0%
- Beta
- 1.15
- Book value / share
- −$3.96
- Price / book
- -0.72
About Entero Therapeutics, Inc.
Entero Therapeutics, Inc. built an AI-based software and device platform that helped utilities, retailers and large power users manage energy load and distributed energy resources. Its Aggregation Management Platform used IoT, AI/ML and edge analytics to forecast, optimize and dispatch flexible demand.
The company also researched targeted, non-systemic therapies for gastrointestinal diseases. It served residential and small business, commercial and utility, technology and hyperscale customers. Based in Edinburgh, United Kingdom, it had offices in Prague, Czechia, and Mississauga, Canada.
The stock was delisted from the Nasdaq in January 2026, with a last trade on January 29, 2026 at $2.85.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Edinburgh
- Employees
- 2
- IPO date
- October 11, 2016
- Delisted
- January 29, 2026
- SEC CIK
- 1604191
Entero Therapeutics financials before the delisting
The last 5 fiscal years Entero Therapeutics reported as a public company, fiscal year ending December.
ENTO revenue and net income
ENTO earnings per share
ENTO annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$18.1M | −$12.90 |
| FY2023 | $0.00 | −$15.8M | −$161.74 |
| FY2022 | $0.00 | −$14.6M | −$11.11 |
| FY2021 | $0.00 | −$58.5M | −$6.54 |
| FY2020 | $0.00 | −$32.7M | −$1.44 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Entero Therapeutics stock FAQ
What happened to Entero Therapeutics stock?
Entero Therapeutics was delisted from the Nasdaq in January 2026. The final close was $2.85 on January 29, 2026.
Can I still buy ENTO stock?
No. ENTO is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on January 29, 2026.
What was the last price of ENTO?
ENTO last closed at $2.85 on January 29, 2026, which valued the company at about $9.58M.
How did Entero Therapeutics do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Entero Therapeutics reported revenue of $0.00 and net income of −$18.1M.
When did Entero Therapeutics go public?
Entero Therapeutics shares started trading on October 11, 2016.
ENTO no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.